Position in CYTK
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$8,520,618
+$1,690,629 QoQ
Shares Held
100,019
-3.5% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#132
of 477 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 37%
Shared 0%
None 63%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PEREGRINE CAPITAL MANAGEMENT LLC holds $166,405,812 across 19 Biotechnology names. CYTK ranks #8 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
29,732 | $27,584,457 | |
| 2 | MIRM |
Mirum Pharmaceuticals, Inc.
|
88,820 | $10,398,157 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
164,894 | $9,953,001 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
162,714 | $9,310,495 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
37,285 | $9,126,249 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
226,350 | $8,759,745 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
25,790 | $8,634,234 | |
| 8 | CYTK |
Cytokinetics Inc
This page
|
100,019 | $8,520,618 |
All Filings in CYTK
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,520,618 | 100,019 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $6,829,989 | 103,626 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $6,866,259 | 108,062 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $8,488,517 | 154,449 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $5,237,765 | 158,528 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $6,259,070 | 155,737 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $7,072,134 | 150,343 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $7,440,100 | 140,911 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $7,617,762 | 140,601 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $8,861,413 | 126,393 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $10,980,103 | 131,514 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $6,029,401 | 204,664 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $5,895,347 | 180,728 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $7,017,449 | 199,416 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $7,337,752 | 160,143 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $7,211,007 | 148,834 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $6,855,829 | 174,493 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $8,081,267 | 219,540 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $9,862,600 | 216,380 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $10,310,847 | 288,496 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $8,394,423 | 424,175 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $10,386,846 | 446,554 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $11,547,113 | 555,684 | Shares | Sole | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||